Atlas Trials

A Study Testing the Use of a Perivascular Sirolimus Formulation (Sirogen) in ESRD Patients Undergoing AV Fistula Surgery

Clinical trial NCT05425056 · COMPLETED

Trial details

NCT number
NCT05425056
Sponsor
Vascular Therapies, Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Complication of Renal DialysisEnd Stage Renal DiseaseEnd Stage Kidney DiseaseESRDChronic Kidney FailureComplication of HemodialysisVascular Access ComplicationArteriovenous Fistula
Start date
2022-08-26
Primary completion
2025-03-18
Enrollment
136

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.